Cargando…
Safety, tolerability, pharmacokinetics and pharmacodynamics of single oral doses of BI 187004, an inhibitor of 11beta-hydroxysteroid dehydrogenase-1, in healthy male volunteers with overweight or obesity
BACKGROUND: The study characterizes safety, tolerability, pharmacokinetic and pharmacodynamic profiles of single rising doses of the 11beta-hydroxysteroid dehydrogenase-1 (11beta-HSD1) inhibitor BI 187004 in healthy men with overweight or obesity. METHODS: This was a randomized, double-blind, parall...
Autores principales: | Bianzano, Susanna, Heise, Tim, Jungnik, Arvid, Schepers, Cornelia, Schölch, Corinna, Gräfe-Mody, Ulrike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364686/ https://www.ncbi.nlm.nih.gov/pubmed/34391480 http://dx.doi.org/10.1186/s40842-021-00130-x |
Ejemplares similares
-
Safety, tolerability, pharmacodynamics and pharmacokinetics following once‐daily doses of BI 187004, an inhibitor of 11 beta‐hydroxysteroid dehydrogenase‐1, over 28 days in patients with type 2 diabetes mellitus and overweight or obesity
por: Bianzano, Susanna, et al.
Publicado: (2022) -
Selective Inhibition of 11beta-Hydroxysteroiddehydrogenase-1 with BI
187004 in Patients with Type 2 Diabetes and Overweight or Obesity: Safety,
Pharmacokinetics, and Pharmacodynamics After Multiple Dosing Over 14
Days
por: Bianzano, Susanna, et al.
Publicado: (2022) -
Pharmacokinetic and pharmacodynamic effects of comedication of clopidogrel and dabigatran etexilate in healthy male volunteers
por: Härtter, Sebastian, et al.
Publicado: (2012) -
11β-Hydroxysteroid Dehydrogenase 2 in Preeclampsia
por: Kosicka, Katarzyna, et al.
Publicado: (2016) -
Microbial Hydroxysteroid Dehydrogenases: From Alpha to Omega
por: Doden, Heidi L., et al.
Publicado: (2021)